MMRd tumors showed a trend towards better RFS (HR: 0.59; 95% CI: 0.30–1.17) while p53 abn had a significantly worse outcome (HR: 2.44; 95% CI: 1.34–4.465).
← all excerpts
The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions.
1
—
—